Sign in to view content

One-Year Outcome of Intravitreal Ziv-Aflibercept Therapy For Nonresponsive Neovascular Age-Related Macular Degeneration

Jay Chhablani, MD

Video
Published 2017

Related

APEX: A Phase II Randomized Clinical Trial Evaluating the Safety andPreliminary Efficacy of X-82 Administered Orally in the Treatment of Exudative AMD
Michael N. Cohen, MD
Updates from the Field
2020
Fluctuations in Central Foveal Thickness and Vision Outcomes With AntiVEGF Therapy for Neovascular Age-Related Macular Degeneration
Veeral S. Sheth, MD, MBA, FASRS, FACS
Updates from the Field
2020
New Biomarkers of Angiogenesis in AMD Using OCT Angiography
David Sarraf, MD
Updates from the Field
2017

Category: AMD-Neovascular

Wet AMD

See more